Categories Earnings, Health Care
Medtronic (MDT) Q2 results exceed expectations; lifts FY20 EPS outlook
Medtronic plc (NYSE: MDT) reported stronger-than-expected earnings and revenues for the second quarter of 2020. The management also revised up its full-year 2020 earnings guidance. The stock gained about 2% early Tuesday, following the announcement.
Adjusted earnings of the Irish medical technology firm rose 7.4% year-over-year to $1.31 per share. Analysts had forecast earnings of $1.28 per share. Net income, on a reported basis, was $1.36 billion or $1.01 per share, up from $1.12 billion or $0.82 per share last year.
Revenue up 3%
Second-quarter revenues moved up 3% annually to $7.7 billion and surpassed the market’s prediction for $7.66 billion. Revenues of the Cardiac and Vascular Group, the company’s largest unit, was almost unchanged at $2.86 billion. The Minimally Invasive Therapies Group and Restorative Therapies Group registered growths of 4.6% and 6% respectively.
Related: Retail space gets busy as firms see opportunity in healthcare
“We reported another quarter of solid results, reflecting our continued focus on executing to our commitments across Medtronic. Our broad-based performance this quarter demonstrates the consistency of our execution, the strength of our innovation, and the benefit of our business and geographic diversification,” said Omar Ishrak, CEO of Medtronic.
Guidance
The management said it continues to expect revenue growth to be about 4%, on an organic basis, in the whole of 2020, with growth accelerating in the second half. The top-line is expected to be negatively affected by 0.8-1.2% if the current exchange rates hold.
The company also revised up its full-year adjusted earnings guidance to the range of $5.57 per share to $5.63 per share from the earlier outlook of $5.54-$5.60 per share. Recent investments in the pipeline have started to pay off, which is expected to translate into revenue growth during the remainder of the year.
Also see: Medtronic Q1 2020 Earnings Conference Call Transcript
Medtronic shares reached a record high prior to the second-quarter report, after gaining steadily since the beginning of the year.
Most Popular
Infographic: How UnitedHealth Group (UNH) performed in Q1 2025
UnitedHealth Group (NYSE: UNH) reported its first quarter 2025 earnings results today. Total revenues were $109.6 billion compared to $99.8 billion in the same quarter a year ago. Net earnings
INFY Earnings: Infosys Q4 profit drops despite an increase in revenues
Infosys (NYSE: INFY) Thursday reported an increase in revenues for the fourth quarter of 2025. However, Q4 profit declined year-over-year. The software firm’s revenues increased 3.6% year-over-year to $4.73 billion
AXP Earnings: Key quarterly highlights from American Express’ Q1 2025 financial results
American Express Company (NYSE: AXP) reported its first quarter 2025 earnings results today. Consolidated total revenues net of interest expense were $17 billion, up 7% year-over-year. Revenues grew 8% on